Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to content or layout.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These are maintenance changes and do not affect the study content.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page version updated from v3.4.0 to v3.4.1. There are no changes to the study details, outcomes, or core content presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedA glossary toggle ('Show glossary') was added and the update-label capitalization adjusted. The footer now shows 'Revision: v3.4.0' replacing 'v3.3.4'.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4; this does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a Locations section with California as a study location and updated the page revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.